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Abstract

MEDICATION-RELATED PROBLEMS EXPERIENCED BY PATIENTS DURING
TRANSITIONS TO ASSISTED LIVING

By Deanna Stephanie Flora, Pharm.D., M.S.

A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University.

Virginia Commonwealth University, 2012

Major Director: Patricia W. Slattum, Pharm.D., Ph.D.
Associate Professor and Geriatric Pharmacotherapy Program Director
Department of Pharmacotherapy and Outcomes Science

Medication reconciliation is a systematic and comprehensive review of
medication regimens during care transitions aiming to prevent adverse drug events.
Poorly executed transitions negatively impact patient welfare and cause financial
burden. Medication-related problems (MRPs) experienced during transitions to an
assisted living facility (ALF) were evaluated.
Data was collected from pharmacy records for transitions to an ALF over three
months, including demographics, medications, potentially inappropriate medications,
and MRPs. MRPs were categorized and summarized using descriptive statistics.

Forty-five patients (71% female) experienced 59 transitions. Average age was
85.6 years. Median length of stay away from the ALF was three days. There were
averages of 18.3 pre-transition medications, 12.5 medications in the discharge orders
and/or upon ALF admission, and 15.9 final medications. 979 MRPs were identified,
mostly no indication documented, followed by underuse, overuse, and non-adherence.
Many of the identified MRPs are potentially preventable. Interventions are
needed to reduce MRPs during ALF transitions.

CHAPTER 1
Background

Older adults commonly experience transitions in care within health care settings
and between health care settings. The types of care transitions, barriers to effective
transitions, assessments of transitions, and recommendations for improving transitions
are discussed. The assisted living setting is one setting involved in care transitions of
older adults. Less focus has been placed on studying this setting, most likely due to the
variations in regulations between states and difficulty in obtaining data for research in
this setting. Assisted living facilities are defined and the Virginia regulations are
discussed, along with demographic information. Patients are prone to medicationrelated problems during care transitions; therefore, the classification and effect of
medication-related problems are reviewed. Pharmaceutical care and medication
reconciliation are discussed as ways to address medication-related problems. Studies
from the literature are reviewed as well as the gaps in the literature regarding
medication-related problems during transitions involving the assisted living setting.
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I. Transitions

a. Types
Transitional care has been defined as a set of actions with the purpose of
ensuring the coordination and continuity of care as patients experience transitions.1
Care transitions may occur within a health care setting or between different health care
settings. For example, patients may transition between units in the hospital as their
condition changes. Additionally, transitions in care may include admission or discharge
from a hospital and transfers to long-term care (LTC) or home care. Care transitions
are common occurrences in the lives of older adults with both acute and chronic
conditions, and involve the patients, caregivers, physicians, nurses, pharmacists, social
workers, and other health care professionals.2
Transitions in care are very common in LTC settings, which include assisted
living facilities, nursing homes, skilled nursing facilities, and hospice care. LTC settings
provide comprehensive, longitudinal, patient-centered services, including formal and
informal health and support services.1 Within the LTC environment, transitions include
transfers from home, emergency departments, and hospital settings.
The importance of care transitions are illustrated by the fact that more than 25%
of nursing home residents receive care from an emergency department each year.1
Patients are often admitted to the hospital for acute care and/or LTC settings for postacute care. It has been noted that almost 5 million patients over 65 years of age
experienced more than 15 million transitions during a two year period.1 After discharge
to the community, over 1.1 million of these patients experienced subsequent health care
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use in hospital, emergency department, and institutional settings.1 Prevalent issues
with transitional care are suggested by the frequent subsequent use of health care in
the older adult population, some of which is potentially preventable.
Ideally, transitions should involve a comprehensive care plan involving health
care professionals who are available, experienced, and have access to relevant medical
information.1 A person-centered approach should be employed that takes into account
the patient’s goals, preferences, and clinical status.1

b. Barriers
The literature regarding care transitions for older adults primarily focuses on
barrier identification or problems leading to patient risk and lack of safety.3 However,
there are many challenges to improving the quality of transitional care. Barriers to
effective care transitions occur at three levels: the delivery system, the clinician, and
the patient.4 Institutions often function in isolation despite the fact that collaboration
across health care institutions is central to effective care transitions.5 Additionally,
access to an electronic health information system is not available in all health delivery
systems and available systems do not communicate with each other.5
Barriers for interprofessional teams involve communication gaps and lack of
timely information.3 Even when collaboration occurs, inaccurate or incomplete
communication can result in medication discrepancies. These discrepancies include
discontinuation of use; dose changes in existing medications caused by adverse drug
events; drug omission; incorrect drug; prescribing errors; dispensing errors;
unintentional non-adherence; incomplete, inaccurate, or illegible discharge instructions;
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and duplicate therapy.6 Underuse, misuse, and overuse of medications are problems
that need to be addressed.
Medication errors, noncompliance issues, nursing home placement, increased
caregiver burden, and increased health care costs have been identified as markers of
poor transitions.7 Poorly executed transitions in care may result in fragmentation of
care, poor clinical outcomes, inappropriate use of emergency department services, and
hospital readmission.8 Improper transitions in care can lead to adverse events for
patients.9 Transitions at shift changes may cause a perpetuation of issues such as a
failure to accurately diagnose an underlying medical illness as is illustrated in a case
scenario by Beach et al.10 Discontinuity of care may threaten the patient’s safety and
quality of patient care.10

c. Assessments
Assessment tools are instrumental in measuring the quality of transitional care.
Coleman et al. designed and tested the Care Transition Measure (CTM) as a patientcentered measure of the quality of care delivered to older adults receiving care across
multiple settings.11 Participants included older adults recently discharged from the
hospital that received subsequent care at a skilled nursing facility or home setting.11
Coleman et al. identified four domains from focus group data including information
transfer; patient and caregiver preparation; support for self-management; and
empowerment to assert preferences.11 The full 15-item CTM contains three items that
focus on medications, specifically on understanding the purpose for taking each
medication, how to take each medication (including how much to take and when), and
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the possible side effects of each medication.12 The CTM was found to be highly
relevant and comprehensive and may be a useful health system performance
evaluation tool.11 The CTM has also been shown to perform in a more diverse
population of a national sample of African American, Hispanic American, and ruraldwelling individuals aged 18 to 90 years.12 Parry et al. found that the 3-item CTM
accurately predicts the score on the full 15-item CTM, which may lead to lower cost and
response burden.12 Additionally, Shadmi et al. assessed the validity and reliability of the
Hebrew and Arabic translations of the CTM.13 The Hebrew and Arabic translations of
the questionnaire were found to be reliable and valid for the assessment of patients’
transitions between hospital and community care.13 The CTM is also a valid and
reliable measure for evaluating care transition quality in Singapore.14
Hallmarks of successful care interventions have been identified by Sims-Gould et
al. based on semi-structured interviews.3 These hallmarks include a focus on
information gathering and communication in addition to patient autonomy and care
pathways (physical and medical benchmarks).3 Future attempts to improve transitions
in care should focus on these hallmarks. Formal feedback loops for sharing information
and letting go of rigid care pathways may be two approaches for breaking barriers.3

d. Recommendations
Recommendations have emerged from studies focusing on approaches to
improving transitions in care. The Transitional Care Model (TCM), a team-based care
delivery system led by a nurse, was developed to improve care transitions.15 The aim of
the TCM is to align the care system with the needs, preferences, and values of the
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patient and caregiver in order to obtain improved outcomes and lower costs.15 The
TCM includes comprehensive discharge planning and follow-up care at home for
chronically ill, high-risk, older adults.15 It focuses on the patient and caregiver in terms
of managing symptoms, educating and promoting self-management, collaborating,
assuring continuity, coordinating care, maintaining relationships, screening, and
engaging elder and caregiver.15 The TCM targets older adults with two or more risk
factors, such as a history of recent hospitalizations, multiple chronic conditions or
medications, and poor self-health ratings.15 Key components of the TCM are the
transitional care nurse; an evidence-based plan of care; home visits; continuity of care
between physicians and follow-up visits from both the transitional care nurse and
physician; focus on each patient’s needs; active engagement; early identification and
response to risks; multidisciplinary approach; physician-nurse collaboration; and
communication between the patient, caregivers, and health care providers.15,16 The
TCM has resulted in a reduction in preventable hospitalizations, improved health
outcomes, enhanced patient satisfaction, and a decrease in total health care costs.15
It is also important to recognize barriers and facilitators impacting the TCM.
Naylor lists several barriers to implementation of the TCM including legal, regulatory,
and administrative; organizational culture and standard operating procedures;
enrollment and marketing of innovation; patient and provider needs and expectations;
defining roles of staff; and information technology needs.15 Facilitators of the TCM
include strong champions; good fit for the organization; all involved and fully engaged
from start to finish; flexibility; awareness of external climate; marketing plan; and
milestones and success measures.15
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A large health plan integrated the TCM and found health status and quality of life
improvements; specifically, there was a decrease in re-hospitalizations and total
hospital days.16 Also of note is a cost savings was found with the implementation of the
TCM.16
Hospital readmissions have also been successfully reduced with a Transitions of
Care Program that was implemented based on the Transitional Care Model.17 The
Transitions of Care Program utilized home care nurses educated in transitional care that
provided intensive education and follow-up for Medicare patients with chronic diseases
and a high risk of readmission.17
A checklist was developed of processes and elements required for optimal
discharge, which was completed by researchers, process improvement experts, and
hospitalists and endorsed by the Society of Hospital Medicine.9 Medication safety,
patient education, and follow-up plans are the focus of the checklist.9 The final list
contains the following data elements: the presenting problem that precipitated
hospitalization; key findings and test results; final primary and secondary diagnoses;
brief hospital course; condition at discharge; discharge destination; discharge
medications with a written schedule, purpose, cautions, and comparison with
preadmission medications; follow-up appointments with provider’s name, date, address,
phone number, purpose, and suggested management plan; all pending labs or tests
and to whom results should be sent; recommendations from sub-specialty consultants;
documentation of patient education and understanding; any anticipated problems and
suggested interventions; 24/7 call-back number; identify referring and receiving
providers; and resuscitation status and other end-of-life issues.9
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The pharmacist’s role was studied utilizing an intervention that involved
pharmacists, in collaboration with other health care providers, reconciling and optimizing
medications from multiple settings of care.18 The pharmacist also provided care
management and ongoing support for 30 days after discharge.18 The intervention led to
a 30% reduction in readmission rates.18 Novak et al. concluded that pharmacists
managing care transitions between sites reduces unnecessary health care utilization
and cost, as well as provides benefits to the patient allowing the patient to remain
healthy at home after hospitalization.18
A study of Department of Veterans’ Affairs (VA) patients in acute care with subacute needs found that there were 34% of admissions to acute care when a different
level of care would be appropriate.19 Costs can be reduced by identifying patients with
sub-acute needs and admitting or transferring these patients to a more appropriate and
lower cost setting; therefore, the VA should consider developing strategies to identify
patients with sub-acute needs.19
The Transitional Care Center (TCC) is a partnership between a large managed
care organization and five nursing homes and is a sub-acute program with the purpose
of promoting continuity of care for frail older adults.20 Rehabilitation and geriatric
evaluation are provided through the TCC partnership.20 A retrospective study found the
TCC resulted in a lower post-acute length of stay and high patient and physician
satisfaction.20 An economic benefit and improvements in care and utilization outcomes
were also associated with the TCC partnership.20
Not all studies have shown a decrease in hospitalization and costs. An analysis
was conducted summarizing the results of 15 randomized controlled trials of care
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coordination programs, which involved nurse-provided patient education and monitoring
(mostly via telephone).21 The results indicated an inability to show a significant
difference compared to usual care with regards to hospitalizations.21 Peikes et al. also
concluded that care coordination programs are unlikely to yield a decrease in Medicare
expenditures, particularly without a strong transitional care component.21 It is suspected
that the best approach would be to combine an ongoing model with proven transitional
care models to reduce hospital readmissions.21
Regarding emergency care transitions, Beach et al. recommend improving team
situational awareness and communication; creating a culture that encourages joint
accountability; exploring information technology to facilitate effective transfer of relevant
information; and increasing awareness of hazards of transitions and techniques for
successful knowledge transfer.10
Parsons et al. studied emergent care transport patterns in the residential setting
and found significant differences between independent senior apartments, licensed
residential care, and nursing homes, as well as between facilities within these
categories.22 The results indicated that standardization of transfer processes from one
setting to the next are advisable.22 In addition, home health services and other
outpatient services may be necessary.22
Care transitions have also been studied in the field of gerontological social work.
An intervention was studied in which social workers contacted patients transitioning
from an acute care setting to home who were identified based on risk factors.7 A
psychosocial assessment was conducted and a plan of care was developed over the
phone.7 Through interviews with the social workers, themes of surprises after discharge
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were identified as common, many of which cannot be anticipated or addressed ahead of
time.7 Short hospital stays, compressed time frames, and difficulty anticipating
circumstances after discharge make it difficult to prepare and educate patients and
caregivers prior to the transition.7 Social workers also commented on their focus on
incorporating the target client system (patient and caregiver) and action system
(resources to help accomplish goals).7 The theme of relationship building also
emerged. Patients benefited most from participation in the helping relationship with the
social worker.7 These themes highlight the importance of the role of surprises after
discharge, expansion of the view of the client system, and development of a helping
relationship for the success of interventions.7
Encouraging patients and caregivers to actively engage in the patient’s care is
important. Coleman et al. found that encouraging community-dwelling adults admitted
to the hospital and their caregivers to take an active role during care transitions may
reduce rates of subsequent hospitalization.23 The patients and caregivers were
provided tools to promote cross-site communication, encouraged to be active in their
care and assert their preferences, and received help from a transition coach.23
The Canadian Health Services Research Foundation published an article on
connected care, which discussed building successful, patient-centered pathways.24
Important elements of building successful pathways outlined in this article can be
applied to many types of transitions. Recommendations include seeking input on a new
process from all stakeholders; ensuring the process has advantages for all stakeholders
and they are aware of the advantages; and asking for stakeholder feedback on
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improvements and visibly incorporate improvements into the process.24 The result was
improved satisfaction for patients and caregivers.24
Recommendations for improving transitions in care focus on communication
between health care professionals as well as between the patient and the health care
provider.25 Five recommendations were mentioned by Coleman and Williams regarding
executing high-quality care transitions.25 These recommendations include greater
recognition for the role of caregivers; define an appropriate follow-up interval; define
physician accountability for patients who are referred to home health; delineate the role
of the hospitalist in the advanced medical home; and develop the ability to examine
episodes of care.25
Given the growing older adult population, health care professionals need to have
the education and training to meet the needs of this population. There has been a lack
of formal education regarding improving patient care transitions. Tanner et al. identified
one example of a lack in necessary knowledge. Through focus groups and interviews,
deficits in medical knowledge and skills to care for older adults were identified in
academic general internists, which also leads to internists’ frustration with the process
of delivering care to this population.26 Additionally, gaps in knowledge of guiding care
transitions for patients and using multidisciplinary teams effectively were acknowledged;
this also impacts effectively teaching the proper care of older adults.26 These deficits
should be addressed through education and training in order to improve geriatric care.
An online survey indicated that 63% of neurosurgical residents had not received formal
instruction regarding effective handoffs (verbal and written communication during care
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transitions).27 Education regarding effective patient care handoffs should be increased
in training programs.27
Several studies have focused on meeting this need for education through
clerkships, faculty development workshops, web-based modules, and virtual
classrooms. To address this gap, Bray-Hall et al. developed a feasible and effective
program to teach evidence-based transitional care.28 The program, Transition in Care
Curriculum, consisted of interactive sessions and self-directed learning exercises and
was found to improve medical students’ overall combined confidence in transitional care
skills.28 The program also enabled students to identify medication discrepancies during
43% of post-discharge visits and the most common reasons for discrepancies were
found to be patient lack of understanding of instructions and intentional non-adherence
to the medication plan.28
Another attempt to close the education gap involved a mandatory geriatrics
clerkship for third-year medical students focusing on clinical experiences in outpatient
clinics, transitional care units, nursing homes, and hospice programs, in addition to core
didactic sessions.29 This clerkship provided students with sufficient knowledge to
complete the requirements satisfactorily, but results indicated that the students did not
highly value the experience and only a few students were inspired to pursue a career in
geriatrics.29 Powers et al. also mentioned the importance of strong leadership and
administration’s support for the success of the program.29
Another clerkship was implemented for pharmacy students and focused on
transitional care.30 Pharmacy students were involved in transitional care planning for
patients discharged from general medicine services, which included interviewing
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patients; assessing discharge medications; reconciling medications at admission and
discharge; providing medication counseling; and conducting follow-up via phone postdischarge to help with MRPs and other patient concerns.30 The clerkship had an impact
on the number of assessments and interviews of patients, as well as students’ providerpatient and provider-provider communication skills.30 Medication adherence barriers
were also identified and resolved as a result of the students.30 The impact of the
clerkship was not only positive for the students, but also for the hospital and the patient
care services provided.
A faculty development workshop was developed to improve general internists’
knowledge and self-perceived competence in their care of geriatric patients and to
increase their teaching of this population for students.31 Content discussions and small
group role plays were developed focusing on assessment of cognition, function, and
decisional capacity; managing care transitions; and treatment of behavioral symptoms.31
Eckstrom et al. found that the workshop improved knowledge scores and self-perceived
competence.31
A 30-minute, online, case-based module was developed for medical trainees and
students with the intent of increasing their understanding of transitional care.32
Specifically, learners were educated on the importance of effective communication
during the discharge process; the sources of payment for older adults in the health care
system; and the various discharge site options.32 For fourth-year medical students, a
virtual classroom was used to educate on care transitions and how to develop and
implement a safe discharge plan.33 Eskildsen et al. determined that the virtual
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classroom improved students’ confidence and knowledge regarding performing
discharge tasks.33
Care transitions have been researched from a number of angles. Studies
regarding transitions in care focus on different settings of care, barriers to effective
transitions, methods of assessing the quality of transitions, and recommendations for
improvement. Barriers and recommendations may or may not apply to different health
care settings. It is important to understand each setting and setting-specific challenges
in order to develop an approach to improving care transitions.

II. Assisted Living

As previously noted, there are studies in the literature that have focused on
barriers to effective care transitions and recommendations for improving transitions.
Many of these studies have not focused on the assisted living setting. In order to
improve care transitions involving assisted living, an understanding of this unique
setting is needed, including knowledge of the characteristics and regulations.

a. What are Assisted Living Facilities?
Assisted living facilities (ALFs) are congregate “residential settings that provide
or coordinate personal and health care services, 24-hour supervision, and assistance
for the care of four or more adults who are aged, infirm, or disabled,” according to the
Virginia Department of Social Services.34,35 ALFs are not nursing homes and they are a
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non-medical setting.34 ALFs are also not the same as independent living. The goal of
ALFs is to help older adults maintain independence as long as possible. ALFs may
range in size from large houses to apartment buildings.
The differences between ALFs and nursing facilities involve activities of daily
living (ADLs) and instrumental activities of daily living (IADLs). ADLs are basic tasks of
everyday life and include eating, bathing, dressing, toileting, and transferring.36 IADLs
are more complex activities including handling personal finances, cooking, shopping,
traveling, doing housework, using the telephone, and taking medications.36
The Virginia Department of Medical Assistance Services specifies differences
between assisted living and nursing facilities. Two levels of care in ALFs are indicated
as residential living level of care in an ALF and regular assisted living level of care in an
ALF.37 Residential living is the basic level of care and to qualify, individuals must be
rated dependent in only one of seven ADLs; or rated dependent in one or more of four
selected IADLs; or rated dependent in medication administration.37 To qualify for
regular assisted living level of care, an individual must be rated dependent in two or
more of seven ADLs; or rated dependent in behavior pattern.37 Medicaid only pays for
regular assisted living, not residential living level of care in an ALF.37
In contrast, to qualify for a nursing facility, an individual must meet at least one of
the following three categories (meeting all elements within the category) and must have
medical nursing needs.37 An individual has medical nursing needs if the individual’s
medical condition requires observation and assessment to assure evaluation of needs
due to an inability for self-observation or evaluation; or the individual has complex
medical conditions that may be unstable or have the potential for instability; or the
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individual requires at least one ongoing medical or nursing service.37 The three
categories are: Category 1 – rated dependent in two to four ADLs; and rated semidependent or dependent in behavior pattern and orientation; and rated semi-dependent
in joint motion or semi-dependent in medication administration; Category 2 – rated
dependent in five to seven ADLs; and rated dependent in mobility; and Category 3 –
rated semi-dependent in two to seven ADLs; and rated dependent in behavior and
orientation.37

b. Regulations
ALFs are regulated by the state in which the facility is located. Direct care staff in
ALFs are certified nurse aides, nursing assistants, geriatric assistants, or home health
aides, or have completed an approved 40-hour direct care staff training.35 For facilities
licensed for both residential and assisted living care, all direct care staff are required to
have at least 16 hours of training relevant to the population in care annually.35 The 16
hours of training is in addition to required first aid training, CPR training (if taken), and
for medication aides, continuing education required by the Virginia Board of Nursing.35
Individuals cannot live in an ALF if they have certain needs, such as dependent on a
ventilator; require intravenous therapy or injections directly into the vein; have an
airborne infectious disease that requires isolation; take psychotropic medications
without appropriate diagnosis and treatment plans; nasogastric tubes; or require
continuous licensed nursing care.35
Personal assistance and care are provided to each resident of an ALF as needed
including activities of daily living; instrumental activities of daily living; ambulation;
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hygiene and grooming; and functions or tasks such as shopping, transportation, and
correspondence.35 An individualized service plan is created to maximize the resident’s
level of functional ability and should be filed in the resident’s record and a copy should
be accessible at all times to direct care staff. The individualized service plan should be
completed within 72 hours of admission for each resident that is not capable of
maintaining themselves in an independent living status.35 Outcomes should be noted
on the plan or a separate document as progress is made. The individualized service
plan must be reviewed and updated at least once every 12 months and as needed as
the resident’s condition changes.35
Medication management is provided at ALFs. The facility should manage
medications for residents appropriately and have a written plan for doing so.35 The ALF
should have a method for verifying medication orders are accurately transcribed on the
medication administration record (MAR) and no medication, dietary supplement, diet,
medical procedure or treatment can be started, changed, or discontinued without a valid
order from a prescriber.35 Medications include prescription, over-the-counter, and
sample medications. It is particularly important to note that “whenever a resident is
admitted to a hospital for treatment of any condition, the facility shall obtain new orders
for all medications and treatments prior to or at the time of the resident's return to the
facility.”35 The ALF also has the responsibility to be sure the primary physician is aware
of all medication orders.35 Additionally, “a licensed health care professional, acting
within the scope of the requirements of his profession, shall perform a review every six
months of all the medications of the resident.”35 It is important to note that some ALFs
have an on-site pharmacy while others do not.
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It is important that health care professionals involved in the care of ALF residents
are educated on these regulations. A lack of knowledge may lead to health issues for
the resident, such as medication-related problems and poor coordination of care at care
transitions. Obtaining an understanding of this setting and the residents of assisted
living is important in order to provide the best care to the patient during interactions with
the health care system and transitions in care.

c. Demographics
The average cost for assisted living in Virginia is $43,650 annually, compared to
nursing homes that cost $66,100 annually.38 Part time care is available at an annual
cost of $14,100 for day care providers.38 There are 994,359 older adults living in
Virginia.38 There are 6,315 professionally managed assisted living communities
nationwide with approximately 475,500 apartments.39 The average resident of an ALF
in the United States is an 87 year old female widow requiring help with two or more
activities of daily living.39 Medication management has been identified as the most
common reason for an older adult to move into an ALF and it is associated with quality
of life and quality of care.40 Estimates of the number of daily medications taken by ALF
residents range from 3.8 to 6.2.40
According to Martin, ALFs and nursing facilities are comparable in terms of
percentages of residents age 85 and older, Caucasian, and female.41 There are several
differences between these settings. It was reported that 83% of nursing facility
residents were impaired in at least one ADL, which compares to 26% of assisted living
residents.41 Moderate-to-severe dementia was reported in 51% of nursing facility
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residents and 33% of assisted living residents.41 Behavior problems were indicated in
30% of nursing facility residents and 42% of assisted living residents.41 Interestingly,
the medication use in terms of routine medications, antidepressants, antipsychotics, and
anxiolytics were similar in the two settings.41
Of Medicare enrollees age 65 and older, 12% had limitations in IADLs only; 18%
had limitations in one to two ADLs; 5% had limitations in three to four ADLs; 3% had
limitations in five to six ADLs; and 4% were in a LTC facility, according to data from
2009.42 Approximately 3% of Medicare enrollees age 65 and older resided in
community housing with at least one service available and 4% resided in LTC facilities
in 2009.42 The percentage of people residing in community housing with services and in
LTC facilities increased with age.42 Among those residing in community housing with
services, 48% reported access to help with medications.42 A greater number of
functional limitations were noted for residents of LTC facilities than individuals in
community housing with services, which were more than the functional limitations of
traditional community residents.42 In fact, 51% of individuals in community housing with
services had a limitation in at least one ADL, which compares to 26% of traditional
community residents and 84% of LTC residents.42
Impairment and medication management are important issues for LTC residents.
There are specific characteristics of the ALF setting that may complicate transitions and
increase vulnerability of residents. ALFs contain elements of independence similar to
community-dwelling situations, but residents of ALFs are more dependent in IADLs.
ALFs are less regulated and lack the medical support of a nursing facility. The
functional and cognitive status of residents, lack of medically trained staff, increased
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opportunity for miscommunication, and regulatory requirements create challenges
during care transitions to ALFs. Furthermore, the medical team is not on site and may
not function as an interprofessional team.

III. Medication-Related Problems

Provided the vulnerability of assisted living residents, medication-related
problems in this setting should be identified and addressed in order to provide proper
care to the resident. Consequently, the classification and effects of medication-related
problems will be discussed. Pharmaceutical care will also be addressed as it applies to
medication-related problems.

a. Classification
The purpose of pharmacotherapy is to treat conditions and improve the wellbeing of the patient. As stated in the literature, the purpose of administering
medications is to achieve cure of a disease, reduce or eliminate symptoms, slow the
progression of a disease, and/or prevent a disease.43,44 However, medications are a
double-edge sword, as positive and negative effects can occur. Therefore the risk of
diminishing the patient’s quality of life is a very real threat. Negative outcomes may
result from inappropriate prescribing, inappropriate delivery, inappropriate behavior by
the patient (such as noncompliance), patient idiosyncrasies, and/or inappropriate
monitoring.43
20

Medication-related problems can compromise the intended benefits of the
treatment. Although there are a number of variations of the definition, most include
common components. A medication-related problem (MRP) has been defined as “an
event or circumstance involving medication therapy that actually or potentially interferes
with an optimum outcome for a specific patient.”44,45 In addition, some classification
systems include “preventable” in the definition. As van Mil et al. point out, classifying
MRPs is important for the development of pharmacy practice as well as research
focused on pharmaceutical care.45
There have been a number of attempts to create a classification of medicationrelated problems, but no standard set of categories has been adopted. There are
different designations for the categories depending on the classification system and the
approach to developing the classification may vary. The cause of the MRP may be
separated from the problem; the problem may describe the cause; and some may
include a coding system for interventions.45 Additionally, the focus of the classification
system may vary with regards to perspective.
One example is a classification system developed by Strand et al., which
involves eight categories including untreated indications, improper drug selection,
subtherapeutic dosage, failure to receive drugs, overdosage, adverse drug reactions,
drug interactions, and drug use without indication.43 Untreated indications are defined
as medical conditions that require medication, but the patient is not receiving a
medication for the indication. Improper drug selection is defined by a patient taking a
medication for an indication, but is taking the wrong drug. A medical condition treated
with too little of the correct drug describes the subtherapeutic dosage category. If the
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patient has a medical condition as a result of not receiving a drug, it is in the failure to
receive drugs category and includes pharmaceutical, psychological, sociological, and
economic reasons for not receiving the medication. Overdosage involves treating
medical problem with too much of the correct drug. Adverse drug reactions include the
patient experiencing a medical problem as a result of an adverse drug reaction or
adverse effect. If the patient is taking a drug for no medically valid indication, it is
included in the drug use without indication category.43 In this classification system,
problems and causes are not separated, as van Mil et al. point out.45 This is the list of
categories the American Society of Health-System Pharmacists includes in their
statement on pharmaceutical care in 1993, as well as the list mentioned on the
American Society of Consultant Pharmacists website.44,46
Additionally, medication regimens should be screened for appropriateness based
on consideration for individual patient characteristics. Tools have been developed that
can be applied to aid in this screening process. For example, the Beers criteria was
developed by a consensus panel of experts to identify potentially inappropriate
medication use in adults 65 years and older in the United States.47 A systems-defined
medicine review tool, known as the Screening Tool of Older Persons’ potentially
inappropriate Prescriptions (STOPP), was developed by geriatric pharmacotherapy
specialists by a Delphi consensus method.48 Each of these tools are standard
approaches and well-established criteria for identifying potentially inappropriate
medications (PIMs).
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b. Effect
MRPs can lead to a decrease in physical and mental function, and therefore, a
decrease in self-care abilities and quality of life.46 The economic consequences are
also concerning. Older adults are more susceptible to MRPs and the degree of severity
may also be worse in this population.
Hanlon et al. published a literature review concerning medication-related
problems, which provided insight regarding medication use in the older adult population.
Approximately 5% of patients had one or more adverse drug events within the previous
year and approximately 20% used one or more inappropriate medications, as
determined by studies of ambulatory older adults.49 The most common medicationrelated problems identified were drug-disease interactions and duration of use.49
Sixteen percent of older adults in assisted living facilities used one or more
inappropriate medications.49 A prospective case series identified MRPs in home care
patients and found 39% of the 380 charts reviewed required pharmacist intervention.50
Of the 232 MRPs identified, 28% were suboptimal therapy and 24% were the use of
unnecessary medications.50 The majority of recommendations were discontinuing a
medication (38.6%) and consulting the prescriber (23.2%).50

c. Pharmaceutical Care
According to the American Society of Health-System Pharmacists, it is the
pharmacist’s mission to provide pharmaceutical care.44 “Pharmaceutical care is the
direct, responsible provision of medication-related care for the purpose of achieving
definite outcomes that improve a patient’s quality of life.”44 The major functions of
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pharmaceutical care involve identification, prevention, and resolution of MRPs.44,45
Consequently, pharmacists should take the responsibility of addressing MRPs in order
to provide the best care possible to patients regardless of practice setting. It is
important to note that this does not diminish the responsibility of other health care
professionals; rather a collaborative approach should be utilized and continuity of care
should be maintained. Overall, improvements should be made to avoid MRPs resulting
from low health literacy; lack of education for the patient, caregiver, and provider; and
medication information tracking challenges.46 One approach to decreasing MRPs is the
process of medication reconciliation.

IV. Medication Reconciliation

Medication reconciliation involves a systematic and comprehensive review of a
patient’s medication regimen at transitions in care. The goal of medication
reconciliation is to avoid inconsistencies, adverse effects, and duplicate or unnecessary
medications.51 The importance of proper medication reconciliation in transitional care is
brought to light when considering medication changes are common during transfers and
are a cause of adverse drug events.2 Approximately half of adults experience a medical
error after hospital discharge, and 19%-23% experience an adverse event, which is
most commonly related to medications.52 Medication errors and adverse events caused
by a lack of proper medication reconciliation at transitions in care impact patient welfare
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and cause a financial burden.53 These facts underscore the importance of proper
medication reconciliation in achieving safe care transitions.

V. Gap in Literature

There is a lack of information in the literature regarding transitions in care
involving assisted living. Before an appropriate model can be developed to improve
care transitions involving assisted living, we must first understand the type of problems
related to medication use that occur and the barriers to effective transitions.
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CHAPTER 2
Significance and Specific Aims

Multiple chronic conditions impact approximately half of older adults in the United
States.15 Quality of life, functionality, and survival rates decrease as a result of agerelated changes coupled with multiple medical conditions and the concurrent use of
multiple medications. It has been determined that a positive linear relationship exists
between the number of medication-related problems and the number of medications
used.54 An increase in the number of health conditions can lead to usage of an
expanded network of providers and can result in a lack of continuity of care.
Hospital readmission within 30 days of discharge has been observed for almost
one in five Medicare patients.18 A study by Coleman et al. aimed to describe patterns of
post-hospital care transitions.55 The Medicare Current Beneficiary Survey was used to
identify patients 65 years and older who were discharged from an acute care hospital.
Results found that 61.2% of the beneficiaries experienced a single transfer; 17.9%
experienced two transfers; 8.5% experienced three transfers; and 4.3% experienced
four or more transfers.55 Coleman et al. indicated 13.4% to 25.0% of the post-hospital
care patterns were complicated, meaning one or more transfers from lower- to higherintensity care environments.55 This raises concern for patient safety and cost. It is
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important to recognize that the potential for errors increases with an increase in care
transitions.55
It has been noted that almost 67% of adverse events following discharge are
medication related, 29% of which are serious or life threatening and may lead to
emergency department use and unscheduled hospital admissions.30 It has been
determined that up to 60% of adverse drug events are preventable.30 The Institute of
Medicine has stressed the importance of improving the health of older adults and
decreasing costs by referring to it as a national priority.15
It is important to recognize that pharmacist-specific interventions can lead to the
identification and resolution of medication discrepancies, a decrease in the number of
preventable adverse drug events following discharge, and a reduction in the amount of
return visits to the emergency department.30 The cost of care to the health system has
been estimated to increase by $3.8 million annually because of preventable adverse
drug events that result in hospital readmissions.30 Medication reconciliation conducted
by pharmacy students found that nearly half of patients admitted to an emergency
department had at least one medication missing from medication lists recorded at
triage.30
There is lack of literature specifically focused on ALFs in terms of care transitions
and medication-related problems. It has been noted that inappropriate prescribing is
common among assisted living residents.49 Since ALFs are state regulated, it is difficult
to generalize results from studies in this setting. Nonetheless, it is important to
investigate the state of care transitions and medication-related problems in this setting.
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The specific aims of this study are:
1. To summarize demographic information for residents/patients who experienced
one or more transitions to a 200-bed assisted living facility located in Virginia
from their home, hospital, or a nursing home over a three month period.
2. To describe and classify medication-related problems (MRPs) experienced by
patients during transitions to a 200-bed assisted living facility located in Virginia
from their home, hospital, or a nursing home over a three month period.
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CHAPTER 3
Aims 1 and 2

I. Methods

A retrospective medical and pharmacy record review was conducted to address
the aims of this project. Approval for this study was obtained from the Virginia
Commonwealth University Institutional Review Board as it qualified for exemption. Data
was collected from existing medical and pharmacy records at a long-term care
pharmacy in Virginia for patients who transitioned to the approximately 200-bed
assisted living facility from home, hospital, or nursing home between January 1, 2011
and March 31, 2011. This includes new admissions to assisted living from any setting
or readmissions after hospitalization or nursing home stay. The residents of this
assisted living facility are primarily Caucasian and female with an average age of 86
years.
Data was collected from paper documents at the pharmacy including
prescriptions, medication lists, and notes from the pharmacist documented at the time of
the transition for cases of medication reconciliation problems. Demographic data for
each patient and transition were recorded including age, sex, type of institution from
which patient transitioned, length of stay at institution, and reason for transition.
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Medication regimen information was recorded (drug name, indication, strength,
frequency, and directions) prior to the transition, upon admission to the assisted living
facility, and a final list after medication reconciliation by the pharmacist. MRPs, who
identified the MRPs, and the resolution of the MRP were recorded. The Strand et al.
classification was modified for this study, as described in Table 1.43 MRPs were
categorized as: 1) PIM: potentially inappropriate medication utilization for specific
patient characteristics based on the Beers47 and STOPP48 criteria for medication lists
prior to the transition, upon admission to the assisted living facility, and after medication
reconciliation by the pharmacist; 2) OU: overuse, including drug dose too high, drug
with no medically valid indication, or therapeutic duplication; 3) UU: underuse, including
drug dose too low or additional drug therapy needed; 4) DDI: any type of drug
interaction detected (not screened); 5) ADE: adverse drug event or drug allergy
(detected, not screened); 6) NA: non-adherence to prescribed therapy or drug therapy
inaccessible; or 7) NI: no indication recorded (an indication must be documented on the
order as required for administration of all prescription and over-the-counter medications
and dietary supplements for assisted living residents in Virginia). Any MRPs that could
not be easily categorized were labeled as miscellaneous (MISC) and described
qualitatively after consulting with the pharmacist for further details.
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Table 1. Classification of MRPs and Comparison to Strand et al. Classification
Strand et al.
Classification Used
Comparison
Classification43
PIM: potentially inappropriate PIMs are defined by
Improper Drug Selection:
medication utilization for
Beers and STOPP
patient has a drug
specific patient characteristics criteria in this study.
indication, but is taking the
based on the Beers47 and
wrong drug
48
STOPP criteria
OU: overuse, including drug
dose too high, drug with no
medically valid indication, or
therapeutic duplication

Drug Use without
Indication and
Overdosage were both
classified as OU.

Drug Use without
Indication: patient is
taking a drug for no
medically valid indication
Overdosage: treating
medical problem with too
much of the correct drug

UU: underuse, including drug
dose too low or additional drug
therapy needed

Untreated Indications
and Subtherapeutic
Dosage were both
classified as UU

Untreated Indications:
medical problem that
requires drug therapy, but
the patient is not receiving
a drug for the indication
Subtherapeutic Dosage:
medical problem treated
with too little of the correct
drug

DDI: drug interaction

Drug Interactions:
medical problem as a result
of a drug-drug, drug-food,
or drug-laboratory
interaction

ADE: adverse drug event or
drug allergy

Adverse Drug Reactions:
medical problem as a result
of an ADR or adverse effect

NA: non-adherence to
prescribed therapy or drug
therapy inaccessible

Failure To Receive Drugs:
medical problem as a result
of not receiving a drug (for
pharmaceutical,
psychological, sociological,
and economic reasons)
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Classification Used

Comparison

NI: no indication recorded

Category added due to
requirements in Virginia
ALFs

MISC: Any MRPs that could
not be easily categorized were
labeled as miscellaneous and
described qualitatively

This category was
added for any MRPs
other than the above
categories

Strand et al.
Classification43

The data was entered into Microsoft® Excel spreadsheets from the paper
documents by a team of four Doctor of Pharmacy students. Consultation with the onsite pharmacist occurred as needed for clarification and additional information regarding
the documents. After collection, the team reviewed the data and classified MRPs
together until a consensus was reached. The number of MRPs for each transition was
calculated. Patient demographics and MRPs were summarized using descriptive
statistics. MRPs classified as miscellaneous were then examined further to provide
more detailed categorization using the notes collected in the data collection process.
Data analysis was performed at Virginia Commonwealth University School of
Pharmacy. The data was stored using RDataStorage to keep the information secure.
Only research personnel had access to the data.

II. Results

A total of 45 patients (71.1% female) experienced a total of 59 transitions. It was
found that 26.7% of patients who transitioned during the three month period
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experienced more than one transition. The highest number of transitions for a single
patient during this time period was three transitions. At the time of the first transition,
the average age of the patients was 85.6 years (range of 56 to 101 years). The median
length of stay away from the assisted living facility for those transitioning from a facility
was three days (range 1 to 180 days). The length of stay did not include patients
transitioning from home to the assisted living facility. The median length of stay in the
emergency department was one day (range 1 to 7 days) and in the hospital was three
days (range 1 to 15 days), compared to 30 days in the nursing home (range 7 to 180
days). Table 2 presents the study demographics. There was an average of 18.3 pretransition medications (range 6 to 29 pre-transition medications), 12.5 medications
(range 0 to 29 medications) in the discharge orders and/or upon admission to the ALF
(post-transition medication list), and 15.9 medications (range 1 to 32 medications)
following reconciliation by the pharmacist (final medication list).

Table 2. Demographics for Patients Transitioning to Assisted Living
Total Number of Patients
Number (Percent) of Males
Number (Percent) of Females
Average Age of Patients (at time of first transition)
Age Range
Total Number of Transitions
Number of Patients with 1 Transition
Number of Patients with 2 Transitions
Number of Patients with 3 Transitions
Average Number of Transitions Per Patient
Median Length of Stay in Institution
Length of Stay Range
Total Number of Medications in Pre-Transition Medication List
Total Number of Medications in Post-Transition Medication List
Total Number of Medications in Final Medication List
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45
13 (28.9%)
32 (71.1%)
85.6 years
56 to 101 years
59
33
10
2
1.3
3 days
1 to 180 days
678
736
941

A total of 979 MRPs were identified, not including PIMs. The most common MRP
identified was no indication documented on the order, followed by underuse, overuse,
and non-adherence (excluding miscellaneous MRPs and PIMs). As previously
mentioned, a recorded indication is required on each order for all prescription and overthe-counter medications and dietary supplements for assisted living residents in the
Commonwealth of Virginia. Figure 1 shows a graphical representation of the total
number of MRPs by type. It was found that there were a total of 478 prescriptions
without an indication recorded and a total of 267 cases of underuse identified. A total of
171 PIMs were identified based on the total number of PIMs as defined by at least one
of the three criteria (Beers criteria considering diagnoses or conditions, Beers criteria
independent of diagnoses or conditions, and STOPP criteria) in the final medication list
after medication reconciliation by the pharmacist.
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Number of MRPs

500
450
400
350
300
250
200
150
100
50
0

478

267
171*

144
57
1

PIM

OU

UU

1

DDI ADE
MRP Type

31
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Figure 1. Total Number of MRPs by Type
*The PIM total is based on the total number of PIMs as defined by at least one of the
three criteria (Beers criteria considering diagnoses or conditions, Beers criteria
independent of diagnoses or conditions, and STOPP criteria) in the final medication
list after medication reconciliation by the pharmacist.

Figure 2 shows the average number of MRPs per transition by type. Per
transition, there was an average of 8.1 prescriptions without an indication recorded.
Additionally, there was an average of 4.5 cases of underuse per transition. There was
an average of 2.9 PIMs per transition based on the total number of PIMs as defined by
at least one of the three criteria (Beers criteria considering diagnoses or conditions,
Beers criteria independent of diagnoses or conditions, and STOPP criteria) in the final
medication list after medication reconciliation by the pharmacist, divided by the total
number of transitions.
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Figure 2. Average Number of MRPs per Transition by Type
*The PIM average is based on the total number of PIMs as defined by at least
one of the three criteria (Beers criteria considering diagnoses or conditions,
Beers criteria independent of diagnoses or conditions, and STOPP criteria) in the
final medication list after medication reconciliation by the pharmacist, divided by
the total number of transitions.

Miscellaneous MRPs were examined and further categorized into four groups:
incomplete directions; outdated, incorrect, and/or incomplete medication lists;
inconsistent and/or incorrect directions; and incorrect formulation. Incomplete directions
accounted for 90 (62.5%) of the miscellaneous MRPs in this study. Outdated, incorrect,
and/or incomplete medication lists accounted for 38 (26.4%) of the miscellaneous
MRPs, while 14 (9.7%) of the miscellaneous MRPs were due to inconsistent and/or
incorrect directions. Also, there were two (1.4%) cases of incorrect formulations on the
medication list.
The three criteria used to identify PIMs were the Beers criteria considering
diagnoses or conditions, Beers criteria independent of diagnoses or conditions, and
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STOPP criteria. Table 3 details the number of PIMs identified in each medication list
(prior to the transition, upon admission to the ALF, and a final list after medication
reconciliation by the pharmacist) by each of the three criteria. The number of PIMs
identified was higher after medication reconciliation using both the Beers and STOPP
criteria to define PIMs. Beers criteria independent of diagnoses or conditions indicated
27 pre-transition PIMs, 30 post-transition PIMs, and 39 PIMs on the final medication list.
Beers criteria considering diagnoses or conditions indicated 45 pre-transition PIMs, 39
post-transition PIMs, and 56 PIMs on the final medication list. The STOPP criteria
indicated 83 pre-transition PIMs, 93 post-transition PIMs, and 113 PIMs on the final
medication list.

Table 3. PIMs Identified
Medication List
Beers*
Beers**
STOPP
Pre
27
45
83
Post
30
39
93
Final
39
56
113
Total
96
140
289
*Beers criteria independent of diagnoses or conditions
**Beers criteria considering diagnoses or conditions

As previously noted, there were 171 PIMs identified by at least one of the three
criteria in the final medication list after medication reconciliation by the pharmacist. Of
these 171 PIMs, 115 (67.3%) were medications on the medication list prior to the
transition. Regarding “as needed” (PRN) medications, 61 (35.7%) of the 171 PIMs in
the final medication list were PRN. Additionally, 44 (25.7%) out of the 171 PIMs in the
final medication list were added during the resolution of other MRPs. The most
common PIMs in the final medication list after medication reconciliation by the
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pharmacist were identified to be aspirin, promethazine, tramadol, lorazepam, and
amlodipine. Each of these appeared in the list of PIMs in the final medication list
between 10 and 18 times.
The number of transitions and MRPs by setting are detailed in Table 4, with the
exception of PIMs. The majority of transitions to the ALF were from the emergency
department (ED) and hospital. Additionally, the total number of MRPs was found to be
the highest in transitions from the hospital and emergency department. The emergency
department and hospital transitions also indicated the highest number of MRPs in these
settings involved no indication recorded and underuse.

Table 4. Number of Transitions and MRPs by Setting
Total MRPs
Types of MRPs
Number of
Setting
in Each
Transitions
OU UU DDI ADE NA
Setting
Assisted Living
3
37
0
0
0
0
16
ED
17
327
11 145 1
0
3
Home
8
55
2
0
0
0
1
Hospital
16
432
32 88
0
0
7
Nursing Home
12
121
12 33
0
1
4
Not Documented
3
7
0
1
0
0
0
Total
59
979
57 267 1
1
31

NI

MISC

17
129
30
242
59
1
478

4
38
22
63
12
5
144

The pharmacist and researcher identified the majority of the MRPs in this project.
Table 5 shows the total number, and average number per transition, of MRPs identified
by the pharmacist, researcher, home health, and a joint effort between the pharmacist
and patient. Not including PIMs, 71% of MRPs were identified by the pharmacist at the
time of transition. The PIMs were all identified by the researcher and these numbers
are not included in Table 5.
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Table 5. Who Identified the MRPs*
Home
Health
Total
698
276
4
Average Per Transition
11.83
4.68
0.068
*Excludes PIMs, which were all identified by the researcher
Pharmacist Researcher

Pharmacist and
Patient
1
0.017

III. Discussion

MRPs were identified and classified for patients transitioning to an assisted living
facility over a three month period. It is interesting to note 979 MRPs, not including
PIMs, were identified in this study and there were 941 total medications in the final list
following medication reconciliation by the pharmacist. In an effort to reduce the number
of MRPs, interventions targeting the most common MRPs are warranted. Additionally,
given the number of PIMs identified in this study, consideration should be given to
identifying and addressing PIMs at the time of medication reconciliation for every
transition.
Targeted education for the health care professional, patient, and caregiver may
decrease MRPs, particularly the most common MRPs identified in this study. Efforts to
educate health care professionals should focus on those who practice in the hospital
and emergency department settings because the highest number of transitions and
MRPs were identified for transitions from these settings. Educational efforts may
include training regarding the appropriate ALF regulations, such as the need for new
orders and an indication for each order for all assisted living residents in the
Commonwealth of Virginia. Additionally, it may be possible to include these
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requirements in decision support systems in the electronic health record systems.
Education regarding regulations may have an impact on the number of orders without a
documented indication, as well as the amount of underuse found in this study. Many
residents returned to the ALF without prescriptions for their medications that needed to
be continued based on their pre-transition medication list. This may be due to a lack of
awareness that the patient is an assisted living resident with the need for new orders for
every medication the patient will take upon returning to the ALF. The fast pace and
intense responsibility of the acute care setting may also have an impact. However,
complying with the regulations in ALFs may decrease adverse events for the resident if
the assisted living staff is informed regarding the resident’s condition and more time can
be focused on optimizing the medication regimen. Additionally, there is opportunity for
education regarding appropriate prescribing for the older adult population, focusing on
potentially inappropriate medications and preferred treatment choices for this
population. It is important to recognize education should also be provided to the patient
and caregiver regarding the patient’s medical conditions, medications, how to
appropriately take each medication, expectations, what to avoid, and what symptoms
would warrant a call to the provider. It would also be helpful to communicate
information regarding the patient’s medical conditions, medications, and plan to the
assisted living staff that will be providing care.
The MRPs of DDI and ADE were detected, but not screened. This may have
underestimated the number of DDIs and ADEs that occurred because some may not
have been reported. Additionally, cases of NA were noted when a medication was not
accessible to the patient or notification of non-adherence was provided. NA may be
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underestimated in terms of non-adherence. Medication administration records may be
useful in shedding light on the issue of non-adherence. Further classification of MISC
MRPs identified issues such as incomplete directions and inconsistent and/or incorrect
directions, which may indicate a need for focused attention to detail when prescribing.
Transitions involving emergency departments and hospitals resulted in the
highest number of MRPs; therefore, these transitions should be a focus for future
interventions. Before an intervention can be proposed, an understanding of the current
process is needed. For example, when a resident transitions from the ALF in this study
to an acute care setting, the intent is for a paper medication administration record to be
sent with the resident. The hope is the medication administration record ends up in the
hands of the health care professional providing care to the patient. The current study
does not provide sufficient information to determine how often the current and correct
medication list is available to the provider in the acute care setting. However, the data
from this study shows there are a number of patients who return to the ALF with
outdated, incorrect, and/or incomplete medication lists. This may indicate current
medication administration records do not always land in the hands of the provider. This
highlights an opportunity for improved communication and consideration for electronic
records shared between settings so the most updated information is available to all
health care professionals involved in the patient’s care. Utilization of information
technology should be considered for future interventions to improve communication.
The number of MRPs identified in this study suggests an emphasis is needed on
medication reconciliation at each transition. The quantity of MRPs surrounding care
transitions may be decreased by designating qualified professionals at each setting as
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the contact persons charged with ensuring that medication reconciliation occurs. This
should be done for each patient upon admission and prior to discharge. On average,
the pharmacist identified 11.83 MRPs per transition, excluding PIMs; this highlights the
amount of effort the pharmacist focuses on medication reconciliation and transitional
care in this setting. The pharmacist identified the majority of the MRPs in this study;
therefore, the pharmacist could provide valuable input regarding the development of
interventions needed to reduce MRPs. Pharmacists have the potential to decrease
health care costs by addressing MRPs. Future research investigating the cost of MRPs
in the ALF setting is also needed.
An interesting finding in this study was the number of PIMs identified was higher
after medication reconciliation using both the Beers and STOPP criteria to define PIMs.
This may be due to the pharmacist dealing with more urgent matters at the time of
transition and medication reconciliation; consequently, the pharmacist may plan for
PIMs to be addressed at the time of medication review rather than at the time of
transition. It may also be impacted by the fact that some of the post-transition
medication lists were missing most of the patient’s medications because new orders
were not written (as required by Virginia ALF regulations). As previously mentioned, a
number of the PIMs in the final medication list after medication reconciliation by the
pharmacist were identified as PRN medications. Others were medications on the
medication list prior to the transition and some were added during the resolution of other
MRPs. These results indicate there are multiple possible reasons for the increase in
PIMs after medication reconciliation. It is also important to note some of the PIMs
identified may be appropriate for the individual patient. Criteria used to identify PIMs
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should not replace clinical judgment. An appropriate monitoring plan should also be
implemented.
It was found that the STOPP criteria identified a higher number of PIMs than
each application of Beers criteria in this study. This is consistent with previous studies
in the literature. One possible explanation is the STOPP was developed more recently
than the Beers criteria applied in this study. Again, criteria used to identify PIMs are not
the final word on medication appropriateness, rather a screening tool to identify
medications that may require additional evaluation prior to use in certain patients.
Although medications are technically included in the Beers or STOPP criteria, valid use
occurs in practice and may be appropriate for an individual patient; thus, clinical
judgment should be utilized. A comprehensive view of the patient’s needs, preferences,
and medical conditions is necessary to appropriately evaluate and reconcile a patient’s
medications.
The lack of consensus regarding definitions of MRPs or the classification system
for MRPs in the literature makes it difficult to compare results from various studies. It
would be helpful to have a clear, standard, accepted definition and classification system
for MRPs. This may help in the comparison of future studies in the literature, as well as
to increase awareness of MRPs for both practitioners and researchers.
A strength of this study is the data was collected and MRPs were categorized as
a team; this strengthens the accuracy of the classifications as a consensus was
reached. This approach may also decrease errors in the data because the information
was reviewed by more than one researcher. Additionally, the researcher had access to
the pharmacy staff, which improved the availability and accuracy of the information
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obtained in this study. Many assumptions were minimized with access to the
pharmacist for clarification or verification of understanding the information provided in
the medical and pharmacy records. This study contributes to the small body of
literature focused on care transitions involving assisted living.
Several limitations should be acknowledged regarding this study. It is possible
that not all transitions were captured. Transition information was obtained from the
pharmacist for the three month period. Additionally, since the total number of residents
is unknown for this time period, the rate of transitions within the community cannot be
calculated. As is typical for the ALF setting, access to patient comorbidities, lab values,
adverse drug events, and monitoring plans was inconsistent; therefore, the number of
MRPs may be underestimated. In most cases, the pharmacist was only provided with
prescriptions and/or discharge orders. It is important to note that the pharmacist was
aware of the study purpose and time period, which may have influenced the results.
An additional limitation is the STOPP and Beers criteria were applied to all
patients in this study including the two patients who were less than 65 years of age.
Furthermore, the STOPP and Beers criteria were not created specifically for the
assisted living setting and the criteria may not be as appropriate for application in this
setting. The STOPP criteria was developed with a focus on the hospital setting.48 The
2003 Beers criteria was updated for ambulatory and nursing facility populations and was
developed using literature focused on medication use in community-dwelling older
adults and older adults living in nursing homes, as well as a panel of experts selected to
represent acute, long-term, and community practice settings.47 Given this information,
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application of the Beers criteria to assisted living may be more appropriate than the
application of the STOPP criteria.
Also, this study was conducted in one ALF in Virginia; thus, the results may not
be generalizable to other populations or facilities in other states as regulations vary by
state. Characteristics of ALFs can vary greatly even within the same state; therefore, it
is difficult to generalize results and compare these results to other studies. Studying an
ALF without an on-site pharmacy may yield different results. Given the wide variety of
ways that pharmacy services are provided to ALFs and the variation in the pharmacist’s
engagement (versus other facility staff), it may be difficult to generalize results to other
ALFs in Virginia. Additional studies in various settings would be needed in order to
draw further conclusions regarding other long-term care facilities.
Since the analysis of data for this study, an update to the Beers Criteria was
completed and published;56 therefore, another limitation of this study is the use of the
2003 Beers Criteria. The 2012 Beers Criteria has been altered from 2003; it lacks
medications that are no longer available and includes medications that have become
available since 2003. It also updates research and appropriate prescribing information.
Future application of the 2012 Beers Criteria to this data is planned.
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CHAPTER 4
Conclusion

MRPs arising during transitions of care to assisted living were identified; many of
these are potentially preventable through effective care transitions and medication
reconciliation. A number of potential approaches for improvement were discussed.
Past studies have demostrated that education has improved knowledge and confidence
of providers and has had a positive impact on the patient care provided. It is
hypothesized that education provided to health care professionals, patients, and
caregivers may improve care transitions involving assisted living. Appropriate health
care professionals should be tasked with medication reconciliation at each setting for
each care transition. A focus should be placed on improving communication between
health care professionals, patients, caregivers, and settings. A consensus definition for
MRPs and classification system should be determined and utilized. Additionally, the
lack of information in the literature focused on assisted living care transitions should be
addressed. A future study to identify barriers to effective transitions in this setting and
ways to improve these care transitions from the LTC perspective has been proposed.
Once an understanding of the barriers to effective transitions is obtained, an
intervention to improve care and reduce MRPs during transitions involving assisted
living should be designed, evaluated, and ultimately implemented.
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CHAPTER 5
Proposed Next Step

I. Specific Aim

The specific aim of this study is to identify barriers to effective transitions to
assisted living facilities in Virginia, as well as possible ways to improve these transitions.

II. Methods

Key informant interviews will be conducted with staff members involved in care
transitions (e.g., pharmacy, nursing, marketing, and resident services personnel at two
assisted living facilities in Virginia as well as staff at LTC pharmacies). Both assisted
living facilities with and without on-site pharmacy services will be included.
Primary contacts at each assisted living facility will be informed about the study
and asked which staff members should be approached for an interview at the facility.
Initial contact will be made via a phone call from the researcher to ask if he/she is willing
to be interviewed. Staff members will be asked for their consent prior to the interview.

47

Interviewees will not be identified by individual name or facility name. A general
description of the facility and his/her role will be used rather than facility name or precise
job title. Appendix A includes the interview session information and questions.
Interviews will be recorded to improve understanding of the responses. However,
recorded interviews will be transcribed and once the transcription is determined to be
error free, the recording will be destroyed. Responses to interview questions will be
analyzed to identify themes.
Data analysis will be performed at Virginia Commonwealth University School of
Pharmacy. The data will be stored using RDataStorage to keep the information secure.
Only research personnel will have access to the data.
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Appendix A

Key Informant Interview Session

The following questions will be asked of interviewees in addition to clarifying
questions as needed. Each interview length is estimated at approximately 30 minutes.
Consent will be obtained prior to the interview. Participation in this interview is voluntary
and may be discontinued at any time.
No personally identifiable information will be collected. Interviewees will not be
identified by individual name or facility name. A general description of the facility and
his/her role will be used rather than facility name or precise job title. Any recorded
interviews will be transcribed and once the transcription is determined to be error free,
the tape will be destroyed.

Interview Questions

With regards to medication-related problems during transitions to assisted living:
1. What are your job responsibilities with respect to care transitions and
medications?
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2. What is the current process for handling medications during a transition (moving
into the assisted living facility versus returning from a nursing home or hospital)?
3. Other than yourself, who else is involved in managing the transitions process?
4. What do you see as the barriers to effective transitions?
5. Are there examples you can share when transitions went well, and when they did
not?
6. What ideas do you have for improving transitions?
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